FMR LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,769,047
-50.2%
19,230,692
+0.2%
0.00%
-50.0%
Q2 2023$91,897,147
-57.1%
19,185,208
-49.3%
0.01%
-20.0%
Q1 2023$214,455,934
+104.9%
37,822,916
+102.4%
0.01%0.0%
Q4 2022$104,657,061
-12.4%
18,688,761
+0.4%
0.01%
-16.7%
Q3 2022$119,481,000
+87.3%
18,610,733
+0.1%
0.01%
+100.0%
Q2 2022$63,802,000
-35.4%
18,601,212
+34.0%
0.01%
-25.0%
Q1 2022$98,810,000
-13.9%
13,877,865
+0.7%
0.01%0.0%
Q4 2021$114,763,000
+19.9%
13,777,070
+0.1%
0.01%0.0%
Q3 2021$95,755,000
-68.9%
13,757,785
+6.5%
0.01%
-66.7%
Q2 2021$308,120,000
+21.9%
12,919,073
+5.2%
0.02%
+9.1%
Q1 2021$252,859,000
-9.0%
12,280,673
+8.3%
0.02%
-12.0%
Q4 2020$277,746,000
-8.5%
11,336,573
+5.8%
0.02%
-19.4%
Q3 2020$303,410,000
+1010.1%
10,717,400
+86.6%
0.03%
+933.3%
Q2 2020$27,332,000
+24.5%
5,742,076
-6.6%
0.00%0.0%
Q1 2020$21,955,000
-2.1%
6,149,746
-5.4%
0.00%
+50.0%
Q4 2019$22,422,000
-21.8%
6,499,118
-9.1%
0.00%
-33.3%
Q3 2019$28,667,000
+9.9%
7,148,846
-11.8%
0.00%0.0%
Q2 2019$26,088,000
-34.8%
8,101,946
+39.2%
0.00%
-40.0%
Q1 2019$39,998,000
+44.4%
5,822,145
-5.0%
0.01%
+25.0%
Q4 2018$27,700,000
-40.4%
6,128,386
+0.1%
0.00%
-20.0%
Q3 2018$46,446,000
-11.4%
6,119,349
+0.4%
0.01%
-16.7%
Q2 2018$52,422,000
+17.2%
6,095,600
+0.0%
0.01%
+20.0%
Q1 2018$44,737,000
-27.4%
6,094,953
+0.3%
0.01%
-28.6%
Q4 2017$61,623,000
-36.8%
6,077,221
+0.0%
0.01%
-41.7%
Q3 2017$97,437,000
+42.4%
6,074,596
+0.3%
0.01%
+33.3%
Q2 2017$68,436,000
+0.3%
6,056,294
+0.1%
0.01%0.0%
Q1 2017$68,216,000
+13.9%
6,052,919
+0.0%
0.01%
+12.5%
Q4 2016$59,906,000
-19.3%
6,051,063
+0.2%
0.01%
-20.0%
Q3 2016$74,218,000
-56.9%
6,038,875
+1.9%
0.01%
-58.3%
Q2 2016$172,207,000
+10.3%
5,927,976
+0.8%
0.02%
+9.1%
Q1 2016$156,122,000
-24.1%
5,878,052
+0.3%
0.02%
-21.4%
Q4 2015$205,570,000
+18.7%
5,858,365
+0.2%
0.03%
+12.0%
Q3 2015$173,233,000
-20.3%
5,844,546
+11.6%
0.02%
-10.7%
Q2 2015$217,396,0005,238,4650.03%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 12,682,876$93,092,00026.99%
ARK Investment Management 2,406,723$17,665,0000.88%
Virtus ETF Advisers LLC 76,713$563,0000.49%
Bison Wealth, LLC 33,929$249,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,525$143,0000.10%
Rock Springs Capital Management LP 220,000$1,615,0000.07%
FEDERATED HERMES, INC. 1,766,681$12,968,0000.04%
Spark Investment Management LLC 79,500$583,0000.04%
A.R.T. Advisors, LLC 45,952$337,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 88,684$651,0000.01%
View complete list of SERES THERAPEUTICS INC shareholders